Jacob Engellau

Medicin och livsvetenskap

1. Adjuvant Chemotherapy 20%
2. Adjuvant Radiotherapy 9%
3. Allogeneic Cells 8%
4. Angiosarcoma of the breast 13%
5. Bacteremia 8%
6. Blood Vessels 10%
7. Bone and Bones 10%
8. Bone Marrow 11%
9. Bone Neoplasms 9%
10. Cell Biology 11%
11. Denosumab 33%
12. DNA Mismatch Repair 18%
13. Doxorubicin 18%
14. Durapatite 16%
15. Ependymoma 10%
16. Extremities 20%
17. ezrin 11%
18. Fine Needle Biopsy 16%
19. G-T mismatch-binding protein 33%
20. Giant Cell Tumor of Bone 45%
21. Growth 13%
22. Head and Neck Neoplasms 7%
23. Hemangiosarcoma 9%
24. Immunoglobulin Isotypes 9%
25. Incidence 9%
26. Intensity-Modulated Radiotherapy 18%
27. Juvenile Xanthogranuloma 12%
28. Large-Core Needle Biopsy 10%
29. Malignant Fibrous Histiocytoma 39%
30. Necrosis 13%
31. Neoadjuvant Therapy 13%
32. Neoplasm Metastasis 22%
33. Neoplasms 49%
34. Neurilemmoma 9%
35. Observer Variation 9%
36. Organs at Risk 15%
37. Osteosarcoma 17%
38. Pediatrics 15%
39. Radiation Effects 9%
40. Radiation Oncology 9%
41. Radiotherapy 37%
42. Recurrence 21%
43. Registries 9%
44. Sarcoma 100%
45. Stem Cell Transplantation 8%
46. Survival 12%
47. Sweden 16%
48. Therapeutics 10%
49. Thoracic Wall 8%
50. Whole-Body Irradiation 18%